212 related articles for article (PubMed ID: 21519172)
1. [Does combination therapy of aspirin plus antiplatelet therapy increase the risk of upper gastrointestinal hemorrhage?].
Kim JH
Korean J Gastroenterol; 2011 Apr; 57(4):205-6. PubMed ID: 21519172
[No Abstract] [Full Text] [Related]
2. [The effect of aspirin alone or aspirin plus additional antiplatelets therapy on upper gastrointestinal hemorrhage].
Bae SE; Kim SE; Jung SA; Yoon SY; Shim KN; Jung HK; Kim TH; Yoo K; Moon IH
Korean J Gastroenterol; 2011 Apr; 57(4):213-20. PubMed ID: 21519174
[TBL] [Abstract][Full Text] [Related]
3. [Prevention of GI bleeding due to antiplatelet agents: a labyrinth!].
Bretagne JF
Presse Med; 2009 Dec; 38(12):1722-6. PubMed ID: 19914029
[No Abstract] [Full Text] [Related]
4. The prevalence of co-administration of clopidogrel and proton pump inhibitors.
Shrestha K; Hughes JD; Lee YP; Parsons R
Qual Prim Care; 2011; 19(1):35-42. PubMed ID: 21703110
[TBL] [Abstract][Full Text] [Related]
5. Incidence, predictors, and outcomes of gastrointestinal bleeding in patients on dual antiplatelet therapy with aspirin and clopidogrel.
Alli O; Smith C; Hoffman M; Amanullah S; Katz P; Amanullah AM
J Clin Gastroenterol; 2011; 45(5):410-4. PubMed ID: 20975574
[TBL] [Abstract][Full Text] [Related]
6. [Does dual antiplatelet therapy always require gastroprotection? Tailored medical therapy should prevail over the generalized prescription of proton pump inhibitors in patients on dual antiplatelet therapy].
Marcucci R
G Ital Cardiol (Rome); 2010 Jun; 11(6):481-7; discussion 487. PubMed ID: 20922874
[No Abstract] [Full Text] [Related]
7. Improving outcomes with antiplatelet therapies in percutaneous coronary intervention and stenting.
Hobson A; Curzen N
Thromb Haemost; 2009 Jan; 101(1):23-30. PubMed ID: 19132185
[No Abstract] [Full Text] [Related]
8. Dual antiplatelet therapy with clopidogrel and aspirin for secondary stroke prevention.
Wang Y; Chen W; Wang Y
Curr Cardiol Rep; 2015 Oct; 17(10):89. PubMed ID: 26294261
[TBL] [Abstract][Full Text] [Related]
9. Single antiplatelet therapy for patients with previous gastrointestinal bleeds.
Gellatly RM; Ackman ML
Ann Pharmacother; 2008 Jun; 42(6):836-40. PubMed ID: 18413689
[TBL] [Abstract][Full Text] [Related]
10. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
[TBL] [Abstract][Full Text] [Related]
11. [Antiplatelet therapy after aspirin-induced upper gastrointestinal bleeding].
Johansen M
Tidsskr Nor Laegeforen; 2006 Nov; 126(21):2802-4. PubMed ID: 17086221
[TBL] [Abstract][Full Text] [Related]
12. Management of upper gastrointestinal haemorrhage complicating dual anti-platelet therapy.
Henriksen PA; Palmer K; Boon NA
QJM; 2008 Apr; 101(4):261-7. PubMed ID: 18252776
[TBL] [Abstract][Full Text] [Related]
13. Optimal drug therapy after aspirin-induced upper gastrointestinal bleeding.
Struijk M; Postma DF; van Tuyl SA; van de Ree MA
Eur J Intern Med; 2012 Apr; 23(3):227-30. PubMed ID: 22385878
[TBL] [Abstract][Full Text] [Related]
14. Clopidogrel versus aspirin and esomeprazole to prevent recurrent bleeding.
Wolk MJ; Jacobs AK
N Engl J Med; 2005 Apr; 352(16):1716-8; author reply 1716-8. PubMed ID: 15843675
[No Abstract] [Full Text] [Related]
15. Reducing the risks of gastrointestinal bleeding with antiplatelet therapies.
Cryer B
N Engl J Med; 2005 Jan; 352(3):287-9. PubMed ID: 15659730
[No Abstract] [Full Text] [Related]
16. Is gastroduodenal biopsy safe in patients receiving aspirin and clopidogrel?: a prospective, randomized study involving 630 biopsies.
Whitson MJ; Dikman AE; von Althann C; Sanyal S; Desai JC; Bamji ND; Kornacki S; Harpaz N; Bodian CA; Cohen LB; Miller KM; Aisenberg J
J Clin Gastroenterol; 2011 Mar; 45(3):228-33. PubMed ID: 20717045
[TBL] [Abstract][Full Text] [Related]
17. Risk and management of upper gastrointestinal bleeding associated with prolonged dual-antiplatelet therapy after percutaneous coronary intervention.
Tan VP; Yan BP; Kiernan TJ; Ajani AE
Cardiovasc Revasc Med; 2009; 10(1):36-44. PubMed ID: 19159853
[TBL] [Abstract][Full Text] [Related]
18. A Primer on Bleeding Risk and Management Strategies of Newer Oral Anti Platelet Agents in Cardiovascular Disease.
Yee J; Kumar V; Anuwatworn A; Petrasko M; Stys A
S D Med; 2016 Oct; 69(10):451-457. PubMed ID: 28806011
[TBL] [Abstract][Full Text] [Related]
19. Anticipating and managing bleeding complications in patients with coronary stents who are receiving dual antiplatelet treatment.
Bhala N; Taggar JS; Rajasekhar P; Banerjee A
BMJ; 2011 Jul; 343():d4264. PubMed ID: 21778196
[No Abstract] [Full Text] [Related]
20. Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).
Gupta R; Kirtane AJ; Ozan MO; Witzenbichler B; Rinaldi MJ; Metzger DC; Weisz G; Stuckey TD; Brodie BR; Mehran R; Ben-Yehuda O; Stone GW
Circ Cardiovasc Interv; 2017 Mar; 10(3):. PubMed ID: 28288963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
